SCROLL
Founded in 2021, GentleGen is a company dedicated to promoting the development of life science engineering through the research and development of life science robots combined with the application of artificial intelligence in life science.
The company has established a service platform for oligonucleotide synthesis, Sanger sequencing, gene synthesis, and protein antibody, as well as an intelligent production workshop.
Get A Quote
Self-developed primer synthesizer, automatic production process
From ng to 100g grade, from technician grade to clinical grade
Experienced team has synthesized more than 10 million bases
Multiple tests are available, ensuring the purity and preventing cross-contamination
GMP laboratory with ISO13485:2016
Guaranteed primer synthesis mutation rate <0.7‰
Provide DSL, PAGE, HPLC and other purification methods
Support primer requirements at different stages from scientific research to industry/clinical
Can assist in the declaration, assist in primer/probe performance testing and provide corresponding reports
Automated production platform overall, reducing human error, higher efficiency, lower cost, more stable cycle
Team of business management and gene synthesis technology with extensive experience in the industry
Fastest delivery in the industry (less than 72h at the earliest)
Well-established codon optimization, quality tracking, machine learning, order automation platform system
Adherence to customer-centered values and team structure design
Scalable increase in capacity and stable lead times
Rigorous QC process and high quality plasmid production ability
Competitive pricing and sustainable cost-reduction production models
Automated production platform
Professional and mature operational team
Well-established codon optimization, quality tracking, machine learning, order automation platform system
Rapid lead time, from gene synthesis to standard antibody delivery in just two weeks
Selection of high secretion signal peptides and independent construction of high expression vectors
Mammalian cell (CHO/HEK293) high expression system
Strict quality control, purity ≥95%, endotoxin <1 EU/mg
High throughput, 200+ clones in a single trial
A large-scale and diverse cell bank；
Multiple efficient transfection methods such as electroporation, liposomes, lentiviruses, and PB transposons systems;
One-stop gene editing service, including sgRNA design, sgRNA synthesis, cell gene editing and CRISPR off-target evaluation etc.
A strong pre-sales and after-sales service system focusing on customers, providing one-stop and customized services;
Professional and mature operational team
Fast turn around time, high quality, and high stability: The Illumina platform combines with the high-performance computing platform to enable fast and stable sequencing data analysis and delivery.
Rich experience in sample handling, involving tissues, cells, whole blood, serum, plasma, FFPE and other experimental samples;
Strict data quality control: strict quality control system to ensure accuracy
Self-developed genomic data analysis pipelines, providing customized BI analysis
Variable scales from μg to mg level;
Modified or unmodified, cap or uncap RNA synthesis;
Linear or circular RNA synthesis;
Integrated production process from gene to mRNA synthesis and QC analysis；
Uniform mRNA poly(A) tail
Advanced purification and QC analysis available
Experienced supporting team
Construction of quality system
6S standardized
management
Guarantee of quality system
01.Corrective and preventive measures（CAPA）
02.Regular internal audits and management reviews
03.System for document creation control and alternation
04.Analytical tracking of quality trends
05.ISO9001:2015 ISO13485 quality system
2F, Building 4. No.111, Wusongjiang Rd, Wuzhong, Suzhou, China
Copyright © GentleGen Technology Co., Ltd - All Rights Reserved
